The Tumor Immune Microenvironment in Breast Cancer Progression

被引:4
|
作者
Fjortoft, Marit Otterlei [1 ,2 ]
Huse, Kanutte [3 ]
Rye, Inga Hansine [1 ,2 ,4 ]
机构
[1] Oslo Univ Hosp, Radium Hosp, Div Canc Med, Dept Canc Genet,Inst Canc Res, Oslo, Norway
[2] Univ Oslo, Inst Clin Med, Oslo, Norway
[3] Oslo Univ Hosp, Radium Hosp, Div Canc Med, Dept Canc Immunol,Inst Canc Res, Oslo, Norway
[4] Oslo Univ Hosp, Inst Canc Res, Dept Canc Genet, Ullernchaussen 70, NO-0379 Oslo, Norway
关键词
Breast cancer; tumor immune microenvironment; subtypes; progression; KILLER-CELL ACTIVITY; INFILTRATING LYMPHOCYTES; SUPPRESSOR-CELLS; DENDRITIC CELLS; DOUBLE-BLIND; LYMPH-NODES; MACROPHAGES; CHEMOTHERAPY; SUBTYPES; ACCUMULATION;
D O I
10.2340/1651-226X.2024.33008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The tumor microenvironment significantly influences breast cancer development, progression, and metastasis. Various immune cell populations, including T cells, B cells, NK cells, and myeloid cells exhibit diverse functions in different breast cancer subtypes, contributing to both anti-tumor and pro-tumor activities. Purpose: This review provides an overview of the predominant immune cell populations in breast cancer subtypes, elucidating their suppressive and prognostic effects. We aim to outline the role of the immune microenvironment from normal breast tissue to invasive cancer and distant metastasis. Methods: A comprehensive literature review was conducted to analyze the involvement of immune cells throughout breast cancer progression. cResults: In breast cancer, tumors exhibit increased immune cell infiltration compared to normal tissue. Variations exist across subtypes, with higher levels observed in triple-negative and HER2+ tumors are linked to better survival. In contrast, ER+ tumors display lower immune infiltration, associated with poorer outcomes. Furthermore, metastatic sites commonly exhibit a more immunosuppressive microenvironment. Conclusion: Understanding the complex interaction between tumor and immune cells during breast cancer progression is essential for future research and the development of immune-based strategies. This comprehensive understanding may pave the way for more effective treatment approaches and improved patients outcomes.
引用
收藏
页码:359 / 367
页数:9
相关论文
共 50 条
  • [1] IMPACT OF TUMOR IMMUNE MICROENVIRONMENT ON BREAST CANCER PROGRESSION
    Kahharov, Alisher
    BREAST, 2023, 71 : S47 - S47
  • [2] The Immune Microenvironment of Breast Cancer Progression
    Tower, Helen
    Ruppert, Meagan
    Britt, Kara
    CANCERS, 2019, 11 (09)
  • [3] Immune microenvironment as a factor of breast cancer progression
    Anatolii Romaniuk
    Mykola Lуndіn
    Diagnostic Pathology, 10
  • [4] Immune microenvironment as a factor of breast cancer progression
    Romaniuk, Anatolii
    Lyndin, Mykola
    DIAGNOSTIC PATHOLOGY, 2015, 10
  • [5] The role of the tumor microenvironment in breast cancer progression
    H Min
    J Yao
    M Allinen
    L Cai
    K Polyak
    Breast Cancer Research, 7
  • [6] The role of the tumor microenvironment in breast cancer progression
    Min, H
    Yao, J
    Allinen, M
    Cai, L
    Polyak, K
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S7 - S7
  • [7] The Tumor Microenvironment and Immune Response in Breast Cancer
    Monzavi-Karbassi, Behjatolah
    Kelly, Thomas
    Post, Steven R.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (02)
  • [8] Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy Preface
    Kalinski, Pawel
    TUMOR IMMUNE MICROENVIRONMENT IN CANCER PROGRESSION AND CANCER THERAPY, 2017, 1036 : V - VI
  • [9] Study of the tumor microenvironment during breast cancer progression
    Rahil Eftekhari
    Rezvan Esmaeili
    Reza Mirzaei
    Katayoon Bidad
    Stacy de Lima
    Maryam Ajami
    Hedayatollah Shirzad
    Jamshid Hadjati
    Keivan Majidzadeh-A
    Cancer Cell International, 17
  • [10] Tumor microenvironment and breast cancer progression A complex scenario
    Artacho-Cordon, Antonia
    Artacho-Cordon, Francisco
    Rios-Arrabal, Sandra
    Calvente, Irene
    Isabel Nunez, Maria
    CANCER BIOLOGY & THERAPY, 2012, 13 (01) : 14 - 24